• McGivney Global

Webinar: What Biotech and Pharma execs need to know about blockchain

Updated: Jul 8, 2018

Blockchain is a buzzword in tech, but does it hold more than hype for the pharma and biotech industry? Explore biopharma business use cases such as value-based contracting and indication-based pricing. Separate the hype from the practical with experts focused on real-world science and applications useful for the biopharma industry.

July 11 at 9 am Pacific/12 pm Eastern

Register for the free webinar

Hear from a panel of medical and tech experts for an online discussion on July 11th at noon ET (9 am pacific) including McGivney Global Advisor's Jennifer Hinkel. We will answer blockchain FAQs, helping you understand key points about blockchain and how it can address biopharma business challenges.

What we'll cover:

  • What blockchain technology is, and what it isn't

  • Potential biopharma use cases, from clinical data management to value-based contracting

  • Common misconceptions and myths about implementing blockchain

  • How to position your company as a blockchain innovator in biopharma

Our panel includes:

Jennifer Hinkel, MSc Partner, McGivney Global Advisors 

Currently a Partner at McGivney Global Advisors, Jennifer has an extensive background in health care financial and economic modeling, pharmaceutical pricing policy and contracting strategy, and cancer drug value. She holds a MSc from the London School of Economics and is a DPhil candidate at the University of Oxford in Evidence-Based Health Care. She has previously held related roles at Genentech, Roche UK, Roche Argentina, NCCN, ASTHO, and UK Parliament.  Jennifer holds patents in health IT methods and blockchain architecture.

Andy Coravos, MBA CEO, Elektra Labs

Andy Coravos is the co-founder and CEO of Elektra Labs and is a Fellow in the Computational Health Informatics Program (CHIP) at Boston Children's Hospital. One of her primary research areas is in the use of digital tools such as sensors and wearables to measure health outcomes as "digital biomarkers." Previously, she was a software developer and management consultant, and holds degrees from Harvard Business School and Duke University. Andy combines expertise in health care outcomes research, economics, and software engineering, and has been a leader in cataloging and evaluating initiatives related to health care and blockchain tech.

Mathew Rose, MD CEO, Saavha 

Dr. Rose is a physician and blockchain technologist with experience in clinical practice, academics, and industry. He is the author of an ONC/NIST Blockchain in Healthcare White Paper and numerous medical publications, and is an alumnus of the Royal College of Surgeons in Ireland, Georgetown University, University of Pennsylvania, and University of Pittsburgh. He has specific expertise in data ownership and privacy in health care and health insurance, and interest in how clinical professionals including physicians interface with technology and data.


Recent Posts

See All

© McGivney Global Advisors 2019